Teligent Pharma, Inc. is recalling 32,544 bottles of Lidocaine Hydrochloride Topical Solution, USP, 4% (50 mL). This prescription-only medication is being recalled because it was found to be superpotent, meaning it contains a higher concentration of the active ingredient than specified. Patients should contact their healthcare provider or pharmacist regarding this recall and for guidance on their medication. Consumers can return any unused product to their pharmacy for a refund.
Using a superpotent lidocaine solution can lead to a higher-than-intended dose, which increases the risk of lidocaine toxicity. This can result in serious adverse health effects such as central nervous system reactions (like seizures or tremors) and cardiovascular issues.
Healthcare consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.